Preparation of a User-Defined Peptide Gel for Controlled 3D Culture Models of Cancer and Disease by Ashworth, J C et al.
Copyright © 2020  JoVE Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported
License
jove.com December 2020 • 166 •  e61710 • Page 1 of 19
Preparation of a User-Defined Peptide Gel for Controlled
3D Culture Models of Cancer and Disease
Jennifer C.  Ashworth1,  Rebecca L.  Morgan1,  Kataryna  Lis-Slimak1,  Kate A.  Meade1,  Sal  Jones1,  Katherine
 Spence2,  Charlotte E.  Slater1,  Jamie L.  Thompson1,  Anna M.  Grabowska1,  Robert B.  Clarke2,  Gilian  Farnie3,  Cathy L. R.
 Merry1
1 Division of Cancer & Stem Cells, School of Medicine, Nottingham Biodiscovery Institute, University of Nottingham 2 Breast Biology Group, Manchester
Breast Centre, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester 3 SGC, Botnar Research Centre, NDORMS,
University of Oxford
Corresponding Author
Cathy L. R. Merry
cathy.merry@nottingham.ac.uk
Citation
Ashworth, J.C., Morgan, R.L.,
Lis-Slimak, K., Meade, K.A.,
Jones, S., Spence, K., Slater, C.E.,
Thompson, J.L., Grabowska, A.M.,
Clarke, R.B., Farnie, G.,
Merry, C.L.R. Preparation of a User-
Defined Peptide Gel for Controlled
3D Culture Models of Cancer and









There is a growing awareness that cells grown in 3D better model in vivo behavior than
those grown in 2D. In this protocol, we describe a simple and tunable 3D hydrogel,
suitable for culturing cells and tissue in a setting that matches their native environment.
This is particularly important for researchers investigating the initiation, growth, and
treatment of cancer where the interaction between cells and their local extracellular
matrix is a fundamental part of the model. Moving to 3D culture can be challenging and
is often associated with a lack of reproducibility due to high batch-to-batch variation in
animal-derived 3D culture matrices. Similarly, handling issues can limit the usefulness
of synthetic hydrogels. In response to this need, we have optimized a simple self-
assembling peptide gel, to enable the culture of relevant cell line models of cancer
and disease, as well as patient-derived tissue/cells. The gel itself is free from matrix
components, apart from those added during encapsulation or deposited into the gel
by the encapsulated cells. The mechanical properties of the hydrogels can also be
altered independent of matrix addition. It, therefore, acts as a ‘blank slate’ allowing
researchers to build a 3D culture environment that reflects the target tissue of interest
and to dissect the influences of mechanical forces and/or biochemical control of cell
behavior independently.
Introduction
The many roles played by the extracellular environment in
cancer development and progression are becoming ever
clearer1 . Recently, detailed proteomic-based analyses have
added to an already convincing literature base, demonstrating
that matrix components derived from cancer-associated
stromal cells, or the cancer cells themselves, are key factors
in events such as the promotion of epithelial mesenchymal
transition and metastatic spread2,3 ,4 . Given this recognized
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importance of the extracellular matrix (ECM), it is becoming
crucial to move towards cell culture platforms that allow
control over the 3D environment presented to cells. In
response to this need, this protocol presents a method for cell
encapsulation and culture in a 3D hydrogel, with user-defined
ECM composition and mechanical properties5 .
Currently, there is a poor correlation between cancer
therapeutic efficacy in 2D in vitro culture, the impact of these
therapeutics in current in vivo (patient-derived xenograft,
PDX) models and their eventual activity in clinical trials6,7 .
This has led to significant failures in the drug discovery
pipeline with an urgent need for improved in vitro models
that allow tested therapeutics to ‘fail early, fail cheap’. Many
researchers use the mouse mastocytoma-derived product
e.g., Matrigel (or similar products) to create 3D matrix-rich
environments to grow and observe cell behavior in vitro,
including PDX-derived and other close-to-patient cells8,9 ,10 .
However, this ‘one size fits all’ approach neglects the complex
role played by matrix proteins/glycans in cancer initiation and
progression.
Recognition of the role of extracellular matrix (ECM) in
the control of cell behavior has also encouraged the use
of 3D culture in or on hydrogels composed of specific
matrix components11 . Whilst this is useful for investigating
specific interactions, these systems suffer from the inability to
separate mechanical and biochemical instructions between
cells and matrix. They may also be difficult to handle and
can give unclear read-outs of cell behavior. Collagen gels
are a key example of this problem, since cell-mediated gel
contraction can dramatically reduce the ability to visualize
cells within the gel5 . There are also some very elegant,
multi-component gel systems, which experts have used
to great effect12,13 ,14 . These can incorporate enzyme-
sensitive linkers and bio-active motifs but are significantly
more complex in their formulation and application than the
system described here.
This protocol describes a method for creating fully defined 3D
culture models, allowing the roles of the ECM in development
and disease to be modeled in vitro. The basis of the 3D
model is a peptide gel, which we have previously described
as an optimization of a simple self-assembling octapeptide
hydrogel5,15 ,16 . By moving away from complex, animal-
derived matrices this system offers a significant benefit of
improved batch-to-batch consistency and improved handling.
In its simple state, the peptide contains no matrix-derived
motifs and effectively provides a ‘blank slate’ onto which the
user can build functionality.
We demonstrate how the mechanical properties of the
peptide gel can be regulated independently, alongside
incorporation of matrix proteins/glycans. The system is highly
tunable, allowing the encapsulation of a range of cell types
in various formats. Importantly for building a cancer model,
stromal cells can also be incorporated: either in direct co-
culture or separated to allow specific analysis of indirect
cancer cell-stroma interactions. Most crucially, the protocol
described here requires no complex knowledge of chemistry
and can be reproduced in any cell culture laboratory without
the need for specialized chemical knowledge or equipment.
We have optimized methods for the study of cell behavior
in the peptide gels, including imaging, rheological analysis,
extraction of material for PCR5  and embedding for
histological assessment. A clear benefit to the simple
hydrogel system is the ability to visualize and study the matrix
deposited by encapsulated cells. The importance of cell-
derived matrices and the benefits of better understanding
of how cells re-engineer their local microenvironment was
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highlighted recently17  and reflects a growing awareness of
the importance of trapping cell-secreted matrix components,
in a similar way to that which occurs in vivo. Harnessing
the ability to model such processes may be one of the
fundamental drivers of the improved patient relevance of
hydrogel-based disease models.
Protocol
1. Dissolution of peptide
1. In a tissue culture hood, add 800 μL of sterile water to a
15 mL tube using a P1000 pipette.
2. Using a fine balance, weigh the peptide powder into a
non-static weighing-boat. Use a mass (in mg) of 1.25x the
desired final peptide gel concentration (in mg/mL, Table
1).
 
NOTE: The method described here will produce a volume
of approximately 1.25 mL of peptide gel per tube at the
point of final gelation. Multiple tubes may be prepared
at a time, or alternatively the volume per tube can be




Mass of peptide Initial NaOH addition
6 mg/mL 7.5 mg 30 µL
10 mg/mL 12.5 mg 60 µL
15 mg/mL 18.75 mg 100 µL
Table 1: Peptide mass and suggested initial NaOH addition for typical final gel concentrations. The ranges of peptide
concentrations listed may be extended in either direction, however, it is more likely that lower peptide concentrations may not
form stable gels, whereas at high concentrations the resulting gel may be too dense to allow sufficient nutrient exchange and
cell viability. The appropriate concentration will require optimization for different cell types and peptide batches.
3. Add the weighed peptide into the 15 mL tube. Flick the
weighing boat to ensure no powder is left behind.
 
NOTE: The peptide powder can be very static, take care
to minimize the loss of powder. It is not necessary to
maintain sterile conditions during steps 1.2 and 1.3 (or
for any pH measurements) as sterilization occurs during
the incubation at 80 °C later in the process.
4. Vortex for 3 min, then centrifuge at 200 x g for 3 min.
5. Incubate the peptide solution in an oven set at 80 °C for
a minimum of 2 h. If undissolved peptide is present after
incubation, repeat step 1.4.
 
NOTE: As uniform heating is essential, a heatblock is
not suitable for this step. However, we have found that
hybridization ovens work well as does a water bath as
long as the peptide solution is fully submerged.
Copyright © 2020  JoVE Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported
License
jove.com December 2020 • 166 •  e61710 • Page 4 of 19
2. Formation of gel precursors
1. Prepare a sterile 0.5 M sodium hydroxide (NaOH)
solution using sterile water.
 
NOTE: Freshly diluted NaOH solution is recommended
for most consistent results.
2. In a tissue culture hood, add 0.5 M NaOH to the center of
the dissolved peptide and mix by slowly stirring with the
pipette tip (Table 1).
3. Vortex the tube for 10 s and centrifuge at 200 x g for 10
s to remove bubbles.
4. If the gel precursor is cloudy, repeat steps 2.2 and 2.3,
adding 5 µL increments of NaOH.
 
NOTE: pH measurement can help determine whether
sufficient NaOH has been added: the optimal pH is
between 9–10.5 and it is preferable not exceed this as
using acids to bring the pH back down can result in gel
inhomogeneity. The precise volume of NaOH required
may vary with peptide source.
5. Once the gel precursor is optically clear and self-
supporting (or only just flowing) on inversion of the 15 mL
tube, add 100 μL of sterile 10x PBS in a tissue culture
hood. Vortex for 10 s and centrifuge at 200 x g for 10 s.
 
NOTE: If the gel precursor is cloudy, repeat step 2.4 until
it becomes clear and semi-solid. If the gel precursor is
liquid (above pH ~10.5), it will not form a stable gel and
should be discarded.
6. Incubate overnight in an oven at 80 °C.
7. Visually check the gel precursor to ensure it is fully liquid
at 80 °C.
1. If the gel precursor is not fully liquid at 80 °C, it
has not been sufficiently neutralized, add NaOH
following step 2.4.
2. If the gel precursor is liquid but air bubbles or small
precipitates are present, flick the tube sharply to
disperse them. If air bubbles or precipitates persist
after flicking the tube, vortex the gel precursor and
centrifuge at 200 x g for 10 s each.
8. After following either of steps 2.7.1 or 2.7.2, incubate
precursor gels for a further 2 h at 80 °C before proceeding
to final gelation.
9. Keep the gel precursors at 80 °C until needed (maximum
48 h).
 
NOTE: The protocol can be paused here, store gel
precursors at 4 °C for up to 4 weeks. If restarting from this
pause point, incubate gel precursors at 80 °C for at least
2 h, and restart from step 2.7. It is strongly recommended
to prepare gel precursors well in advance of them being
needed for the final gelation, to ensure there is sufficient
time for the above modifications if required.
3. Preparation of matrix components for seeding
NOTE: An example calculation for steps 3–5 is shown in
Figure 1. Step 3 and step 4 may be omitted to produce a
matrix-free and/or a cell-free gel respectively.
1. Calculate the total combined volume of cells, matrix and
media required for seeding, allowing for 250 µL to be
added to each 1 mL precursor gel. Multiply this volume by
1.1 to allow for pipetting error. This is the seeding volume,
VS.
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2. For each matrix component, calculate the volume of





NOTE:  VS corresponds to the total volume of seeding
medium required for seeding all gels (step 3.1). Ensure
that the sum of all matrix component volumes does not
exceed VS.
3. Thaw all matrix components thoroughly (refer to
manufacturer’s instructions) and store on ice until
needed.
 
NOTE: Some matrix components will be very prone to
gelation. Refer to manufacturer’s instructions to avoid
this occurring.
4. If an acidic collagen stock solution requiring
neutralization is to be added (refer to manufacturer’s
instructions), prepare the neutralization solution as
follows:
1. Calculate the volume of collagen stock solution, VC,
required using Equation 1.
2. Determine a suitable volume for the neutralization
solution, VN. This should be chosen such that the
combined volume of all matrix additions does not
exceed the seeding volume, VS.
 
NOTE: Generally, a sensible value for VN = 2 x Vc,
but this may be adjusted according to the number
and volume of other matrix components to be added.
3. Calculate the volume of 1 M NaOH required for
neutralization using Equation 2.
 
 (2)
4. Calculate the volume of 10x PBS required in the
neutralization solution using Equation 3.
 
 (3)
5. Combine the calculated volumes of 1 M NaOH and
10x PBS, then make up to VN with sterile water. Mix
well, and store on ice until needed.
 
NOTE: Do not add the acidic collagen at this
point. Premature mixing of the collagen with the
neutralization solution will lead to the initiation
of collagen fibrillogenesis, which can cause
inconsistency in the properties of the final peptide
gel.
4. Preparation of cells for seeding
1. If not already completed, calculate the seeding volume,
VS according to step 3.1.
2. Calculate the cell density required in this cell suspension,
by taking the desired cell density in the final peptide gel
and multiplying by 5.
 
NOTE: The cell suspension is 5x the desired end
concentration to account for dilution upon mixing with the
gel precursor. Cell densities should be optimized for each
new cell line under consideration. Depending on the cell
type, densities between 1 x 104  and 1 x 106  cells/mL in
the final peptide gel may be appropriate.
3. Calculate the total number of cells required for seeding
(multiply the cell density by the seeding volume VS
calculated in step 4.1.).
4. Using standard culture/passage methods for the cells in
use, prepare a cell pellet containing the required quantity
of cells as calculated in step 4.3.
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5. Final gelation/cell encapsulation
1. When ready to begin final gelation, transfer the gel
precursors from the 80 °C oven into a 37 °C water bath.
 
NOTE: The gel precursors should be self-supporting at
37 °C. If they are liquid, it is unlikely that complete
gelation will occur, and the gel precursors should be
discarded.
2. Prepare a 96 well plate, or alternatively a 24 well plate
(or similar) with cell culture inserts.
 
NOTE: Ensure there is a gap between the base of the
insert and the well plate when plating peptide gels in 24
well inserts. This ensures the gel is in contact with media.
3. If matrix is to be added, combine all matrix components
and neutralization solutions (step 3). Make up to VS (step
3.1) using cell culture medium and mix thoroughly. If cells
are to be added, resuspend the cell pellet prepared in
step 4 using the seeding volume VS.
 
NOTE: If no matrix components have been prepared
in step 3, use the cell culture medium for the seeding
volume. This is generally the standard culture medium
for the cell type in use, although this may need to be
validated if a mixture of cell types is being used.
4. Using a P1000 pipette, add 250 μL of the cell/matrix mix
gently on top of the gel precursor.
 
NOTE: Matrix components, particularly basement
membrane extract, may begin to polymerize once added
to the gel precursor. It is, therefore, important to move to
the next step as quickly as possible.
5. Gently mix by the combined action of pipetting and
stirring. The gel is shear thinning so will become easier to
mix with gentle pipetting/stirring. When thoroughly mixed,
add 100 μL to each well of a 96 well plate, or 200 μL to
each cell culture insert.
 
NOTE: When mixing, reverse pipetting using a P1000
set at 200 μL can be beneficial to avoid introducing air
bubbles. The gel may initially be difficult to mix, but on
continued mixing should become easier - this indicates
that the mixing is efficient.
6. Incubate for 10 min at 37 °C in 5% CO2 and a humidified
atmosphere.
 
NOTE: This step is not necessary if the peptide gel
contains no matrix additions.
7. Add 200 μL of media to each well of the 96 well plate, or
1 mL to the outside of the cell culture insert with a few
drops on the top of the gel. Incubate at 37 °C in 5% CO2
and a humidified atmosphere.
8. Change media twice within the next hour, and again after
several hours (or the following day).
 
NOTE: Take care here as the gels will be unstable for
several hours.
9. Change media every 2–3 days (or following standard
culture protocol for the cells in use).
6. Indirect co-culture
NOTE: This method is only applicable where the peptide
gels are seeded into 24 well plate inserts, or similar formats
in which the gel can be supported above a cell monolayer.
Indirect co-culture can be introduced in this case by preparing
a 2D feeder layer of cells on the bottom of the well plate.
1. Prepare a 24 well plate for seeding. This should be a
separate plate to the peptide gels but should be of the
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same brand to ensure compatibility with the inserts used
(see step 5.2).
2. Calculate the cell density needed for seeding the indirect
co-culture, according to the cell type under consideration.
 
NOTE: The cell seeding density should be optimized
for each new cell line under consideration. Cells should
be plated to give approximately 30–50% confluence. As
an example, the human mammary fibroblast cell line
HMFU19 is typically plated at a density of 1-5 x 104  cells/
well.
3. Using standard culture/passage methods for the cells in
use, prepare a cell suspension suitable for seeding at 1
mL/well, using the typical growth medium for these cells.
4. Seed the cell suspension into the well plate, 1 mL per
well.
5. Incubate at 37 °C in 5% CO2 and a humidified
atmosphere to attach for several hours, or overnight.
Then remove the medium from the wells.
6. Using sterile forceps, transfer the 24 well plate inserts
containing the peptide gels into the new wells containing
the pre-seeded cells in 2D. Add 1 mL of medium dropwise
to the exterior of the insert and a few drops on the surface
of the gel.
 
NOTE: Typically, the medium used at this point is the
one suitable for the cells encapsulated in the gel, but the
suitability of this medium for the cells in 2D may need
verification or optimization for the particular experiment
under consideration.
7. Regularly prepare fresh feeder layers to avoid over-
confluence, and transfer peptide gels to these new wells
following the same method as above.
 
NOTE: Typically, cells for indirect co-culture are prepared
at the same time as the peptide gel seeding. Peptide gels
can then be transferred to co-culture at the point of media
change after a few hours or overnight incubation, see
step 5.8.
7. Bulk oscillatory rheology of peptide gels
NOTE: As standard, rheological characterization is carried out
24 h after gel seeding, which should take place in 24 well plate
inserts.
1. Set up and calibrate the rheometer according to
manufacturer’s instructions. Use a parallel plate
geometry with plate diameter as close as possible to the
diameter of the cell culture insert.
 
NOTE: Tests may be carried out at 37 °C if desired,
replicating the environment during culture.
2. Remove the first peptide gel sample to be tested from the
cell culture insert by inverting the insert and cutting out
the plastic membrane using a scalpel.
 
NOTE: Ensure the plate containing the peptide gels is
outside the cell culture incubator for as short a time
as possible prior to testing. Media with a bicarbonate
buffering system relies on the presence of CO2 to
maintain pH. Gels that have been outside the incubator
too long will drift in pH, which can affect rheological
assessment. It can be beneficial to maintain the gels with
10 mM HEPES added to the media to prevent this effect.
3. Carefully transfer the gel to the rheometer plate. Then,
using a scalpel, trim the height of the gel to approximately
1 mm to minimize gel deformation when loaded under the
rheometer plate.
 
NOTE: Be careful not to touch or damage the rheometer
plate when using the scalpel.
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4. Set the parallel plate spacing to 1 mm. Trim any excess
gel that is not covered by the rheometer plates.
5. Run the desired test settings on the rheometer, according
to manufacturer’s instructions.
 
NOTE: For each new sample condition, it is advised to
run an amplitude sweep from 0.1–100% strain to ensure
that all tests are carried out at a strain level within the
sample’s linear viscoelastic region.
8. Live/dead staining of encapsulated cells
1. Remove the medium from the wells, and wash peptide
gels twice with 1x PBS, using the same technique as for
a media change (step 5.7).
2. Remove peptide gels that have been cultured in 24 well
plate inserts following step 7.2. Keep gels in 1x PBS in
the original well plate until ready to stain.
 
NOTE: Take care as the gels can be fragile at this point,
especially after extended culture.
3. Prepare a live/dead staining solution, allowing for 500 μL
stain per 24 well plate insert, or 50 μL per well of a 96 well
plate. A typical stain is 4 μM ethidium homodimer and 2
μM calcein AM in 1x PBS. Protect the resulting solution
from light.
 
NOTE: Concentrations of live/dead reagents may require
further optimization depending on the cell type used and
reagent supplier.
4. Carefully remove PBS from each gel and replace with a
few drops of the staining solution, making sure each gel
is well-covered.
5. Incubate gels in the staining solution in the dark for
10–15 min, then visualize using a confocal/fluorescent
microscope.
 
NOTE: For higher quality images, it can be beneficial
to transfer the gels to glass-bottom dishes of coverslip
thickness.
9. Fixing peptide gels for end-point imaging
1. Wash peptide gels following step 8.1.
2. Add 4% paraformaldehyde (PFA) in 1x PBS: 100 μL for
each well of a 96 well plate and 1 mL for each gel in a 24
well plate insert (a few drops should be added on top of
the gel inside the insert).
 
CAUTION: Paraformaldehyde (PFA) is highly toxic and
is readily absorbed through the skin. It is extremely
destructive to the skin, eyes, mucous membranes, and
upper respiratory tract. PFA should be handled in a
fume hood and users should wear protective clothing and
gloves. Alternative chemical fixatives may be used in the
same way according to the end application.
3. Incubate peptide gels in PFA fixative for 1 h at room
temperature.
4. Remove PFA fixative and wash peptide gels twice with
1x PBS.
 
NOTE: The protocol can be paused here, store fixed
peptide gels at 4 °C in 1x PBS for up to 4 weeks, making
sure the plate is well sealed with paraffin film.
10. Embedding peptide gels for sectioning
NOTE: Embedding peptide gels in 4% agar is a crucial
step prior to paraffin-embedding for immunohistochemistry.
Alternatively, gels may be embedded in 2% agar and
sectioned using a vibratome (typically 500 μm sections give
good results). This is an optional step, producing hydrated gel
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sections that can be beneficial for staining extracellular matrix
localization in the gel, using the methods in section 11.
1. Prepare molten 2% or 4% agar solution in 1x PBS (see
note above), by boiling in a microwave. Allow to cool for
a few minutes before using.
 
NOTE: Molten agar presents a heat hazard – handle
with care using hand and face protection. Once prepared,
agar solution may be stored at 4 °C until needed.
2. Remove peptide gel from the cell culture insert following
step 7.2.
3. Using a plastic Pasteur pipette, cover the base of a
histological embedding mold with a thin layer of agar
solution. Leave to cool at 20 °C for a few seconds.
4. Using a spatula, place the peptide gel into the center of
the agar. Then completely cover the peptide gel in agar.
 
NOTE: The gel should not sink into the agar. If it does,
remove the gel and wait a few more seconds until the
agar has solidified more and try again. Try not to let too
much solidification take place or there will be a weak join
between the two layers.
5. Allow the embedded gel to cool for 1 h at 4 °C before
removing from the histological mold.
 
NOTE: The protocol can be paused here, store
embedded gels at 4 °C in 1x PBS for up to 4 weeks.
6. If immunohistochemistry is to be carried out, put
embedded gels into a tissue processor, and proceed
using standard lab methods.
 
NOTE: Alternatively, embedded gels may be cut into
hydrated sections using a vibratome. Hydrated sections
should be stored in sealed plates at 4 °C in 1x PBS for
up to 4 weeks.
11. Staining cells in gels using
immunocytochemistry
1. Remove the 1x PBS covering the peptide gels/gel
sections. Remove any gels still in 24 well plate inserts
following step 7.2.
2. Cover gels/gel sections in a blocking buffer and incubate
for 30 min at 20 °C.
 
NOTE: A typical blocking buffer consists of 0.5% bovine
serum albumin (BSA) in 1x PBS with 0.1% Triton X-100.
Triton X-100 is toxic and causes serious eye damage,
skin irritation and is very toxic to aquatic life. Users should
wear protective clothing, eye protection and gloves.
3. Prepare primary antibodies in blocking buffer at
optimized working concentrations. Allow 200 μL per 24
well plate gel, 100 μL per gel section, and 50 μL per 96
well plate well.
 
NOTE: Typically, the antibody concentrations used for
3D staining in gels should be double the concentration
used in 2D.
4. Remove blocking buffer and add antibody solution to the
gels dropwise.
5. Seal plate with paraffin film and incubate overnight at 4
°C.
6. Remove antibody solution and wash twice with blocking
buffer.
7. Add secondary antibody following the same procedures
described in steps 11.3 and 11.4.
8. Incubate in the dark overnight at 4 °C, or for 3 hours at
20 °C.
9. Remove antibody solution and wash twice with 1x PBS.
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10. Cover samples in 1:1,000 DAPI solution and incubate at
4 °C in the dark for 1 h.
11. Transfer the gel to a glass coverslip and image by
fluorescent/confocal microscopy.
12. RNA extraction
NOTE: The volumes used in this method are applicable where
the peptide gels are seeded into 24-well plate inserts. Other
gel formats can be used, and volumes adjusted accordingly.
1. Remove the medium from the wells, and wash peptide
gels twice with 1x PBS, using the same technique as for
a media change (step 5.7).
2. Remove peptide gels that have been cultured in 24 well
plate inserts following step 7.2. Place each gel into a
separate 15 mL centrifuge tube.
 
NOTE: Take care as the gels can be fragile at this point,
especially after extended culture.
3. Using a P1000, add 500 μL Trypsin-EDTA (0.25%) to
each tube and pipette up and down to mix, and disrupt
the gel.
4. Incubate gels in the Trypsin-EDTA at 37 °C for 3-5 min.
 
NOTE: Incubation times may require optimization
depending on the cell type used.
5. Add 5 mL of 1x PBS to dilute the Trypsin-EDTA.
6. Centrifuge at 200 x g for 5 min to pellet cells.
7. Remove the supernatant.
 
NOTE: Take care as a gel layer may have formed in
between the cell pellet and the supernatant.
8. Resuspend the cell pellet in lysis buffer, according to
the manufacturer’s instructions, and proceed following
standard protocols for RNA extraction.
Representative Results
The peptide gel fabrication method described here allows the
user to define and create a bespoke 3D culture environment.
While the mechanical environment is determined primarily
by peptide concentration, matrix components of interest may
also be added at controlled densities, as shown by the
example calculation in Figure 1. In its simplest form, however,
the peptide gel protocol provides a method for encapsulating
cells in a matrix-free 3D environment. Figure 2 shows how
this approach may be combined with a wide range of cancer
models, including fluorescently labeled cancer cell lines
(Figure 2A) and patient-derived xenograft (PDX) material
(Figure 2B,C). Importantly, cell lines and PDX material may
both be cultured within the gels in serum-free conditions
(Figure 2C,D), providing a 3D culture system with fully
defined composition.
Since the peptide itself does not contain any cell-binding
motifs, encapsulated cells typically display a rounded
morphology in the unmodified peptide gels. Figure 3A
demonstrates this for human mammary fibroblasts in a 6
mg/mL peptide gel, compared with their classic elongate
morphology seen in pure Matrigel and a pure collagen
gel. Importantly however, the peptide gel protocol allows
incorporation of matrix components of interest. Figure 3A
demonstrates how addition of 200 μg/mL collagen I can
restore the elongate fibroblast morphology in the peptide gels.
Matrix additions can also support the growth and organization
of other cell types, for instance MCF10A, as shown in Figure
3B. In this case, addition of 100 μg/mL collagen I to a 6 mg/
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mL peptide gel allows acinar structures to form by day 7.
Further complexity may also be introduced by incorporation
of a supportive cell layer in indirect co-culture. Figure
3C demonstrates how the combined approach of matrix
incorporation and indirect co-culture with human mammary
fibroblasts can enhance MCF10A growth and organization.
Another important parameter is the concentration of peptide
used in peptide gel fabrication. Figure 4A shows an example
of how controlling peptide concentration, in this case between
4 and 10 mg/mL, results in a stiffness ranging between 100s
to 1000s of Pa. These gels may be fabricated matrix free or
can be created with matrix additions to allow simultaneous
control of both stiffness and composition. Peptide gels with
matrix additions may be sectioned and stained to allow
the distribution of these additions to be visualized. Figure
4B, C show two approaches for doing this: embedding
in 4% agar followed by standard tissue processing and
paraffin embedding for immunohistochemistry (Figure 4B) or
embedding in 2% agar followed by vibratome sectioning and
fluorescent staining (Figure 4C).
When modifying the composition of the peptide gels, it
is crucial to ensure that these changes do not impact
the mechanical environment initially presented to the cells.
Figure 4D demonstrates how modifications to the peptide
concentration can be used to offset any changes to the
peptide gel stiffness on matrix incorporation. Bulk oscillatory
rheology measurements of gel stiffness (storage modulus, G’)
can then distinguish between the effects of gel composition
and stiffness on cell morphology. As shown in the bright
field images, MDA MB 231 cells develop an elongate
morphology on collagen addition to either 10 mg/mL or 15
mg/mL peptide gels. Figure 4E shows that these elongated
cells stain positive for pFAK, indicating an interaction with
their surrounding matrix. The initially matrix-free environment
of the peptide gels also makes them an ideal platform
for studying cellular synthesis and deposition of matrix
components of interest. Figure 4F shows the localized
deposition of collagen I by MCF7 cells encapsulated in 10 mg/
mL peptide gels.
One of the key advantages of the peptide gels is the ease
with which standard laboratory methods can be applied to
their analysis. Material can be extracted for qRT-PCR to
determine gene expression profiles (as shown in our recent
publication5 ). Imaging by bright-field microscopy additionally
allows real-time visualization of cell growth. Figure 5 shows
some of the typical troubleshooting issues that may be
encountered in unsuccessful peptide gels: incomplete mixing
of the gel precursor (Figure 5A,B); incorrect optimization
of peptide concentration (Figure 5C,D) or seeding density
(Figure 5E,F); and incorrect neutralization of acidic collagen
prior to incorporation in the peptide gels (Figure 5G,H).
Peptide concentration and seeding density, in particular, must
be optimized for each cell line and peptide source, to ensure
that the culture environment is appropriately defined, and
representative of the application of interest.
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Figure 1: An example calculation for matrix composition and seeding density. This example workflow describes the
procedure that would be followed to seed two peptide gel precursors with additions of 100 µg/mL collagen, at a final cell
density of 1 x 105  cells/mL. Please click here to view a larger version of this figure.
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Figure 2: Matrix-free peptide gels provide a suitable 3D culture platform for cell line and patient-derived cancer
models. (A) HCT116 colorectal cancer and MCF7 breast cancer cell lines, constitutively expressing the fluorescent markers
mCherry and tdTomato respectively, form cell clusters in 6 mg/mL gels by day 9 (left), and may be imaged live using
fluorescent microscopy (right, scale bar 50 µm); (B) Patient-derived xenograft (PDX) cells from a triple negative breast
cancer patient (BR8) form cell clusters by day 7 in 10 mg/mL peptide gels; (C) PDX cells from estrogen receptor positive
breast tumours (BB3RC31) may be grown in serum-free conditions18 , shown with basement membrane matrix (e.g. Matrigel)
control at matched passage for comparison; (D) MCF7 breast cancer cells are viable in 6 mg/mL peptide gels in matrix-free
and serum-free conditions, as assessed using a LIVE/DEAD cell assay at day 7. KSR = knockout serum replacement, MS
medium = mammosphere medium19 . Scale bar 100 µm unless specified. Please click here to view a larger version of this
figure.
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Figure 3: Peptide gel complexity may be increased by introduction of matrix additions and co-culture. (A) Human
mammary fibroblast cell line HMFU19 requires collagen additions to restore an elongate morphology in a 6 mg/mL peptide
gel, shown with pure basement membrane matrix (e.g. Matrigel) and 1.5 mg/mL rat tail collagen I gel for comparison, scale
bar 50 µm; (B) MCF10A normal breast cells form acinar structures by day 7 in 6 mg/mL peptide gels on addition of 100
µg/mL human collagen I, scale bar 100 µm; (C) Combined addition of matrix components fibronectin/HA (hyaluronic acid,
molecular weight 804 kDa) and HMFU19 in indirect co-culture increase the size and organization of MCF10A acini in 10 mg/
mL peptide gels as assessed by cleaved caspase 3 staining, scale bar 50 µm. Please click here to view a larger version of
this figure.
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Figure 4: Peptide gels allow independent control of stiffness and composition, and assessment of cell-deposited
matrix. (A) Bulk rheology measurements demonstrating a typical stiffness range (storage modulus, G’) achievable by control
of peptide concentration, * indicates p < 0.05; (B) Immunohistochemistry showing staining of 150 µg/mL collagen I in a 10
mg/mL peptide gel with encapsulated MCF7 (day 7, scale bar 100 µm); (C) Immunofluorescence of collagen I distribution
in a 6 mg/mL peptide gel with 200 µg/mL human collagen I, by agar embedding and vibratome sectioning, scale bar 25 µm;
(D) Addition of 200 µg/mL collagen I gives a modest decrease in the storage modulus, G’, of 10 mg/mL peptide gels (bulk
oscillatory rheology), offset by increasing peptide concentration to 15 mg/mL. MDA MB 231 triple negative breast cancer
cells are shown in each condition (day 7, scale bar 50 µm); (E) MDA MB 231 in 15 mg/mL peptide gels with 200 µg/mL
human collagen I show elongation and interaction with the matrix via pFAK staining (day 14, scale bar 50 µm); (F) In situ
staining of MCF7 collagen I deposition in an initially matrix-free 10 mg/mL peptide gel (day 10, scale bar 100 µm). Please
click here to view a larger version of this figure.
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Figure 5: Common peptide gel troubleshooting issues may be resolved using bright-field microscopy. Cells shown
are MCF10A normal breast epithelial cells, at day 7 unless specified. (A) A correctly mixed gel precursor should be optically
clear with no inconsistencies, whereas (B) insufficient mixing/neutralization can cause visible inhomogeneities/streaks in the
peptide gel (white arrows); (C) MCF10A form acinar structures in 6 mg/mL peptide gels on addition of HMFU19 indirect co-
culture, however (D) at 15 mg/mL the peptide concentration is too high to allow acinar formation; (E) MCF10A seeded at 5
x 105  cells/mL form acinar structures in 6 mg/mL gels on addition of 100 μg/mL collagen I, however (F) at 2 x 105  cells/mL
cell density is too low to allow acinar formation; (G) Collagen additions can produce large cell clusters by day 14, however
(H) incorrect addition (collagen neutralization too early in the process) can prevent cluster growth. Scale bar 100 µm. Please
click here to view a larger version of this figure.
Discussion
We have found the peptide gels described here to be a
simple, cost-effective, and flexible solution to support 3D
culture of multiple cell types. By providing full control over
the concentration of peptide used and the protein or glycan
additions made, this method allows the peptide gels to be
carefully tailored to their application.
The crucial advantage of the peptide gels over existing
methods is that matrix composition and mechanical
properties may be controlled independently, using a simple
method that does not require any complex chemical
procedures. The mechanical properties of the peptide gel are
primarily determined by the peptide concentration in the initial
gel precursor. Subsequent addition of cells and/or matrix
components then allows creation of a fully user-defined in
vitro environment. Although matrix additions may alter the
initial mechanical properties of the gel, this may readily be
offset by the independent variation of peptide concentration5 .
This provides a tangible advantage over existing systems,
for instance collagen gels, in which parameters that control
stiffness also commonly result in a change in integrin binding
motifs20,21 .
We have demonstrated the application of the peptide gel for in
vitro culture of cancer cell lines and patient-derived material5 .
The range of stiffness accessible with the peptide gel (in the
range of 100s to 1000s of Pa) is ideally suited to replicate
normal and tumor matrix environments in soft tissues such as
breast. However, we recognize that other applications require
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considerably stiffer environments, e.g. in the 10–20 kPa range
for osseous regeneration. Further modification of the protocol
presented here would be required to extend the achievable
stiffness into this range, which is more typical of alternative
approaches such as alginate gels22 . Similarly, here we have
described a simple method for functionalization by physical
entrapment of matrix proteins/glycans within the peptide gel.
For the applications described here, this approach works
well and is easily adapted for use by non-specialist groups
wishing to use 3D in vitro models of disease. Like many
other hydrogels11 , the peptide used here can be extended
to include cell-binding or other biological motifs and for some
applications this approach may be preferable.
We have identified a few key points that need careful attention
to ensure success. Formation of the gel precursor is a critical
intermediate step that enables the user to check that the
conditions used are correct before cells are incorporated. This
precursor can be stored for several weeks (at 4°C) but must
be incubated at 80 °C and subsequently at 37 °C prior to use.
A suitable precursor will be completely liquid at 80 °C, and
self-supporting at 37 °C. These checks are essential to ensure
that gelation will occur correctly. Cells and/or matrix may then
be incorporated under physiological conditions.
Labs already using 3D matrices will be familiar with the careful
handling needed to encapsulate cells in the peptide gels.
Care must be taken to limit the agitation of cells before and
during the encapsulation steps. We have found that specific
cell types are differentially susceptible to damage during
this process and this must be carefully evaluated by the
user. The concentrations of the peptide gel described here
allow gelation to proceed in a time frame that, for the cells
mentioned, allows cells to be encapsulated before they sink to
the bottom of the casting well but slowly enough that they are
not damaged by this process. It is, however, of note that some
sensitive cell types may require more rapid neutralization to
avoid prolonged exposure to raised pH. In this case, the
addition of 10 mM HEPES to the medium surrounding the
peptide gel can be beneficial.
When adopting the method described in this protocol, it is
very important to carefully consider the quality of the peptide
source. Rather than being used as a functional motif or
coating, the peptide here is the entirety of the non-soluble
portion of the hydrogel. Therefore, any contaminants or
variation in the peptide structure are likely to have a significant
impact on the integrity or capacity to support cell viability in
the final hydrogel. When moving to a new batch of peptide,
care must be taken to ensure that there is good batch-to-
batch consistency from the supplier as well as checking the
behavior of the peptide when forming the gel precursor.
In summary, this protocol describes a 3D culture system with
a crucial focus on the independent control of mechanical and
biological properties. The simplicity and adaptability of the
method makes it suitable for adoption by any cell culture
laboratory, and for a wide range of applications5 . In the
future, this protocol may be extended to allow the covalent
modification of the peptide sequence. This could be combined
with advanced microscopy methods to investigate the tensile
forces exerted by cells on their surrounding matrix. Of key
importance, however, is the ability to distinguish between
artificially incorporated matrix, and matrix synthesized by the
encapsulated cells themselves. This ability to control and
monitor matrix changes over time will allow unprecedented
insights into the roles of cell-matrix interactions in the
development of cancer and other diseases.
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